JULIUS AND SARA ZUCKERMAN CHARITABLE FUND FOR MEDICAL IMAGING

Address
325 CHESTNUT STREET SUITE 610
PHILADELPHIA, PA 19106
Contact
Phone: +1 (215) 238-1510
Nonprofit
NTEE: E11 - Single Organization Support
EIN: 26-1299868

Mission

CONDUCT RESEARCH, DEVELOPMENT AND IMPLEMENTATION OF TECHNOLOGIES FOR THE EARLY DETECTION AND MONITORING OF TREATMENT INTERVENTIONS FOR BLINDING RETINAL EYE DISEASES, CANCERS AND NEURODEGENERATIVE DISEASES.
 20112010
Basic features of the organization
Year of formation2007
Metropolitan statistical area6162
Form of organization
CorporationTrue
Human resources, including compensation
Summary compensation info
Number of employees00
Number of volunteers22
Personnel
Durante, Pascal
TitleTREAS / SECRTREAS / SECR
Name of key/compensated personPASCAL J DURANTEPASCAL J DURANTE
Position of compensated person
Current officerTrueTrue
Average hours per week working for org4.004.00
Reportable compensation from org$0.00$0.00
Other comp, non-reportable, from org and related orgs$0.00$0.00
Corresponding comp from related orgs
Reportable compensation from related orgs $0.00$0.00
Zuckerman, Ralph
TitlePRESIDENTPRESIDENT
Name of key/compensated personRALPH ZUCKERMANRALPH ZUCKERMAN
Position of compensated person
Current officerTrueTrue
Average hours per week working for org5.005.00
Reportable compensation from org$0.00$0.00
Other comp, non-reportable, from org and related orgs$0.00$0.00
Corresponding comp from related orgs
Reportable compensation from related orgs $0.00$0.00
Purpose: mission, activities, & accomplishments
Mission or significant activitiesCONDUCT RESEARCH, DEVELOPMENT AND IMPLEMENTATION OF TECHNOLOGIES FOR THE EARLY DETECTION AND MONITORING OF TREATMENT INTERVENTIONS FOR BLINDING RETINAL EYE DISEASES, CANCERS AND NEURODEGENERATIVE DISEASES.CONDUCT RESEARCH, DEVELOPMENT AND IMPLEMENTATION OF TECHNOLOGIES FOR THE EARLY DETECTION AND MONITORING OF TREATMENT INTERVENTIONS FOR BLINDING RETINAL EYE DISEASES, CANCERS AND NEURODEGENERATIVE DISEASES.
Programs, including revenue & expenses
DONATIONS WILL BE USED TO CONDUCT RESEARCH, DEVELOPMENT AND IMPLEMENTATION OF TECHNOLOGIES FOR THE EARLY DETECTION AND MONITORING OF TREATMENT INTERVENTIONS FOR BLINDING RETINAL EYE DISEASES, CANCERS AND NEURODEGENERATIVE DISEASES, BY NON-INVASIVE METHODOLIGIES, AS WELL AS MINIMALLY INVASIVE TECHNOLOGIES FOR EARLY CANCER DETECTION AND MONITORING OF EFFECTS OF CHEMOTHERAPY. THE CHARITABLE FUND WILL ALSO MAKE GRANTS TO PARTIALLY FUND CLINICAL TRIALS BY OTHER RESEARCH AND EDUCATIONAL INSTITUTIONS.
Program descriptionDONATIONS WILL BE USED TO CONDUCT RESEARCH, DEVELOPMENT AND IMPLEMENTATION OF TECHNOLOGIES FOR THE EARLY DETECTION AND MONITORING OF TREATMENT INTERVENTIONS FOR BLINDING RETINAL EYE DISEASES, CANCERS AND NEURODEGENERATIVE DISEASES, BY NON-INVASIVE METHODOLIGIES, AS WELL AS MINIMALLY INVASIVE TECHNOLOGIES FOR EARLY CANCER DETECTION AND MONITORING OF EFFECTS OF CHEMOTHERAPY. THE CHARITABLE FUND WILL ALSO MAKE GRANTS TO PARTIALLY FUND CLINICAL TRIALS BY OTHER RESEARCH AND EDUCATIONAL INSTITUTIONS.DONATIONS WILL BE USED TO CONDUCT RESEARCH, DEVELOPMENT AND IMPLEMENTATION OF TECHNOLOGIES FOR THE EARLY DETECTION AND MONITORING OF TREATMENT INTERVENTIONS FOR BLINDING RETINAL EYE DISEASES, CANCERS AND NEURODEGENERATIVE DISEASES, BY NON-INVASIVE METHODOLIGIES, AS WELL AS MINIMALLY INVASIVE TECHNOLOGIES FOR EARLY CANCER DETECTION AND MONITORING OF EFFECTS OF CHEMOTHERAPY. THE CHARITABLE FUND WILL ALSO MAKE GRANTS TO PARTIALLY FUND CLINICAL TRIALS BY OTHER RESEARCH AND EDUCATIONAL INSTITUTIONS.
Financial data
Revenue
Total revenue$30,000.00$50,000.00
Revenue from contributions (total)$30,000.00$50,000.00
Investment income, current yr$0.00$0.00
Total revenue from grants, etc., current yr$30,000.00$50,000.00
Total unrelated business revenue$0.00$0.00
Other revenue, current yr$0.00$0.00
Program service revenue (total)$0.00$0.00
Gross receipts$30,000.00$50,000.00
Sources of contributions
Revenue from all other contributions$30,000.00$50,000.00
Other types of revenue
Net rental income$0.00$0.00
Expense categories (totals)
Total functional expenses: sum of all$2,410.00$13,035.00
Total functional expenses: program service $0.00$0.00
Total functional expenses: management and general$2,410.00$13,035.00
Total functional expenses: fundraising$0.00$0.00
Fees for services
Fundraising service fees (total)$0.00$0.00
Assets and liabilities
Total assets$112,551.00$84,961.00
Total assets, beginning of year$84,961.00$47,996.00
Total liabilities$0.00$0.00
Unrestricted net assets, end of yr$112,551.00$84,961.00
Net assets$112,551.00$84,961.00
Net assets, beginning of year$84,961.00$47,996.00
Cash: non-interest bearing$112,551.00$84,961.00
Cash: non-interest bearing, beginning of year$84,961.00$47,996.00
Other financial variables
Revenue less expenses$27,590.00$36,965.00
Total net assets or fund balances$112,551.00$84,961.00
Governance and accountability
Number of voting members22
Number of independent voting members11
Cash accountingTrueTrue
Tax year start date2011-01-012010-01-01
Tax year end date2011-12-012010-12-01
Indicators for schedules (selected)
Org has controlled entityTrueTrue
Org transacted with controlled entity True
Metadata about the filing
E-return type: 990, 990EZ, or 990PF990990
Date e-filing submitted2012-10-112011-09-06
IRS schema version2011v1.22010v3.2
Filing identifier201231359349305848201102239349301040
Use these data in your project Benchmark this organization against its peers